Search research articles
Contact Us
Filters
Showing results (221-230 of 384) with videos related to
Page
of 39
Sort By:
Journal of Vascular Surgery. Venous and Lymphatic Disorders
|
March 20, 2016
Regional and Systemic Prothrombotic Biomarkers in Varicose Vein Patients and Healthy Controls
C R Lattimer, E Kalodiki, M Azzam, et al.
Seminars in Thrombosis and Hemostasis
|
November 5, 1999
Acquired defects of fibrinolysis associated with thrombosis
J Fareed, D A Hoppensteadt, W P Jeske, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1995
Impact of biotechnology in the diagnostic and therapeutic management of cardiovascular disorders
J Fareed, D Hoppensteadt, L Iyer, et al.
Seminars in Thrombosis and Hemostasis
|
January 1, 1991
Experimental and clinical validation of the prophylactic antithrombotic effects of a low molecular weight heparin (enoxaparin)
J Fareed, J M Walenga, D Hoppensteadt, et al.
Thrombosis Research
|
April 1, 1994
Role of tissue factor pathway inhibitor in post surgical deep venous thrombosis (DVT) prophylaxis in patients treated with low molecular weight heparin
R Kijowski, D Hoppensteadt, J Walenga, et al.
Thrombosis Research
|
June 1, 1997
Topical application of low molecular weight heparin in a rabbit traumatic anastomosis model
K Fu, R Izquierdo, D Vandevender, et al.
Seminars in Thrombosis and Hemostasis
|
October 1, 1986
Evaluation of thrombin activity by immunoquantitation of fibrinopeptide A generation
R M Emanuele, J Fareed, J M Walenga, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders
|
March 20, 2016
Blood Sampled Directly from Varicose Veins Reveals Activation of Inflammatory Processes
E Kalodiki, J Fareed, D Syed, et al.
Thrombosis Research
|
July 1, 1988
The inhibition of the generation of thrombin and the antithrombotic effect of a pentasaccharide with sole anti-factor Xa activity
J M Walenga, L Bara, M Petitou, et al.
Seminars in Thrombosis and Hemostasis
|
January 1, 1995
Antithrombin III affinity dependence on the anticoagulant, antiprotease, and tissue factor pathway inhibitor actions of heparins
W Jeske, J C Lormeau, D Callas, et al.
Page
of 39
Search research articles
Search
Showing results (221-230 of 384) with videos related to
Sort By:
Page
of 39
Journal of Vascular Surgery. Venous and Lymphatic Disorders
|
March 20, 2016
Regional and Systemic Prothrombotic Biomarkers in Varicose Vein Patients and Healthy Controls
C R Lattimer, E Kalodiki, M Azzam, et al.
Seminars in Thrombosis and Hemostasis
|
November 5, 1999
Acquired defects of fibrinolysis associated with thrombosis
J Fareed, D A Hoppensteadt, W P Jeske, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1995
Impact of biotechnology in the diagnostic and therapeutic management of cardiovascular disorders
J Fareed, D Hoppensteadt, L Iyer, et al.
Seminars in Thrombosis and Hemostasis
|
January 1, 1991
Experimental and clinical validation of the prophylactic antithrombotic effects of a low molecular weight heparin (enoxaparin)
J Fareed, J M Walenga, D Hoppensteadt, et al.
Thrombosis Research
|
April 1, 1994
Role of tissue factor pathway inhibitor in post surgical deep venous thrombosis (DVT) prophylaxis in patients treated with low molecular weight heparin
R Kijowski, D Hoppensteadt, J Walenga, et al.
Thrombosis Research
|
June 1, 1997
Topical application of low molecular weight heparin in a rabbit traumatic anastomosis model
K Fu, R Izquierdo, D Vandevender, et al.
Seminars in Thrombosis and Hemostasis
|
October 1, 1986
Evaluation of thrombin activity by immunoquantitation of fibrinopeptide A generation
R M Emanuele, J Fareed, J M Walenga, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders
|
March 20, 2016
Blood Sampled Directly from Varicose Veins Reveals Activation of Inflammatory Processes
E Kalodiki, J Fareed, D Syed, et al.
Thrombosis Research
|
July 1, 1988
The inhibition of the generation of thrombin and the antithrombotic effect of a pentasaccharide with sole anti-factor Xa activity
J M Walenga, L Bara, M Petitou, et al.
Seminars in Thrombosis and Hemostasis
|
January 1, 1995
Antithrombin III affinity dependence on the anticoagulant, antiprotease, and tissue factor pathway inhibitor actions of heparins
W Jeske, J C Lormeau, D Callas, et al.
Page
of 39